These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 24157311)

  • 21. First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: the Milan and New-Tokyo (MITO) registry.
    Naganuma T; Chieffo A; Takagi K; Panoulas VF; Mitomo S; Sticchi A; Latib A; Miyazaki T; Sato K; Costopoulos C; Fujino Y; Montorfano M; Carlino M; Nakamura S; Colombo A
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):E63-9. PubMed ID: 25099758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of everolimus- versus paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization (from the SPIRIT-IV Trial).
    Amin AP; Reynolds MR; Lei Y; Magnuson EA; Vilain K; Durtschi AJ; Simonton CA; Stone GW; Cohen DJ
    Am J Cardiol; 2012 Sep; 110(6):765-70. PubMed ID: 22651880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis of long-term outcomes for drug-eluting stents versus bare-metal stents in primary percutaneous coronary interventions for ST-segment elevation myocardial infarction.
    Wallace EL; Abdel-Latif A; Charnigo R; Moliterno DJ; Brodie B; Matnani R; Ziada KM
    Am J Cardiol; 2012 Apr; 109(7):932-40. PubMed ID: 22221949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stents.
    Loh JP; Torguson R; Pendyala LK; Omar A; Chen F; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 Jun; 113(12):1968-76. PubMed ID: 24767975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
    Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW
    J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE Program.
    Farooq V; Vranckx P; Mauri L; Cutlip DE; Belardi J; Silber S; Widimsky P; Leon M; Windecker S; Meredith I; Negoita M; van Leeuwen F; Neumann FJ; Yeung AC; Garcia-Garcia HM; Serruys PW
    Heart; 2013 May; 99(9):626-33. PubMed ID: 23468513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Approach to coronary bifurcation lesions using the everolimus-eluting stent: comparison between a simple strategy and a complex strategy with T-stenting.
    Ruiz-Salmerón RJ; Valenzuela LF; Pérez I; Fuentes M; Rodríguez-Leiras S; Vizcaíno M; Carrascosa C; Marcos F
    Rev Esp Cardiol (Engl Ed); 2013 Aug; 66(8):636-43. PubMed ID: 24776332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-year clinical outcome of patients with bifurcation treatment with second-generation Resolute and Xience V stents in the randomized TWENTE trial.
    Lam MK; Sen H; van Houwelingen KG; Löwik MM; van der Heijden LC; Kok MM; de Man FH; Linssen GC; Tandjung K; Doggen CJ; von Birgelen C
    Am Heart J; 2015 Jan; 169(1):69-77. PubMed ID: 25497250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the first- and second-generation limus-eluting stents for bifurcation lesions from a Korean multicenter registry.
    Cho Y; Koo BK; Song YB; Hahn JY; Choi SH; Gwon HC; Rha SW; Yu CW; Park JS; Bae JH; Lee JH; Jeong MH; Yoon JH; Jang Y; Kim HS
    Circ J; 2015; 79(3):544-52. PubMed ID: 25746538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcome after drug eluting stenting in patients with ST-segment elevation myocardial infarction: data from the REAL registry.
    Campo G; Saia F; Percoco G; Manari A; Santarelli A; Vignali L; Varani E; Benassi A; Sangiorgio P; Tarantino F; Magnavacchi P; De Palma R; Guastaroba P; Marzocchi A
    Int J Cardiol; 2010 Apr; 140(2):154-60. PubMed ID: 19056134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sirolimus- versus paclitaxel-eluting stents for coronary bifurcations intervention: a meta-analysis of five clinical trials.
    Qian J; Chen Z; Ma J; Ge J
    Catheter Cardiovasc Interv; 2012 Oct; 80(4):507-13. PubMed ID: 22045690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
    Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
    EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Five-year long-term clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery disease: the SPIRIT II trial.
    Onuma Y; Miquel-Hebert K; Serruys PW;
    EuroIntervention; 2013 Jan; 8(9):1047-51. PubMed ID: 23339811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dedicated two-stent technique in complex bifurcation percutaneous coronary intervention with use of everolimus-eluting stents: the EES-bifurcation study.
    Kherada NI; Sartori S; Tomey MI; Mennuni MG; Meelu OA; Roy S; Mohanty BD; Baber U; Pyo R; Kovacic JC; Sweeny J; Moreno P; Krishnan P; Dangas GD; Mehran R; Sharma SK; Kini AS
    Int J Cardiol; 2014 Jun; 174(1):13-7. PubMed ID: 24731975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Women treated with second-generation zotarolimus-eluting resolute stents and everolimus-eluting xience V stents: insights from the gender-stratified, randomized, controlled TWENTE trial.
    Tandjung K; Basalus MW; Sen H; Stoel MG; van Houwelingen KG; Louwerenburg JH; de Man FH; Linssen GC; Saïd SA; Kleijne MA; van der Palen J; von Birgelen C
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):396-405. PubMed ID: 23359390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second generation drug-eluting stents versus bare-metal stents for percutaneous coronary intervention of the proximal left anterior descending artery: An analysis of the BASKET-PROVE I and II trials.
    Mangione FM; Biering-Sørensen T; Nochioka K; Jatene T; Silvestre OM; Hansen KW; Sørensen R; Jensen JS; Jorgensen PG; Jeger R; Kaiser C; Pfisterer M; Galatius S
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):867-873. PubMed ID: 28722266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-hospital and one year outcomes with drug-eluting versus bare metal stents in large native coronary arteries: a report from the Evaluation of Drug-Eluting Stents and Ischemic Events registry.
    Gordon PC; Cohen DJ; Kleiman NS; Montgomery JA; Semder CA; Kennedy KF; Keyes MJ; Piana RN;
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E356-64. PubMed ID: 22511502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial.
    von Birgelen C; Basalus MW; Tandjung K; van Houwelingen KG; Stoel MG; Louwerenburg JH; Linssen GC; Saïd SA; Kleijne MA; Sen H; Löwik MM; van der Palen J; Verhorst PM; de Man FH
    J Am Coll Cardiol; 2012 Apr; 59(15):1350-61. PubMed ID: 22341737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of long-term (4-year) outcomes of patients with unprotected left main coronary artery narrowing treated with drug-eluting stents versus coronary-artery bypass grafting.
    Wu X; Chen Y; Liu H; Teirstein PS; Kirtane AJ; Ge C; Song X; Chen X; Gu C; Huang F; Lv S
    Am J Cardiol; 2010 Jun; 105(12):1728-34. PubMed ID: 20538122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.